Stock Trade Compilation Episode Siete
Presidio Production (now trading as FTW) came public via the EQV Ventures SPAC and immediately sketched out a playbook of acquiring low-decline PDP...
GRCE: Looking Ahead to Acceptance
Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTx-104, is a novel injectable formulation of...
149 Views
GRCE: NDA Submitted
Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTx-104, is a novel injectable formulation of...
214 Views
GRCE: Progress Report
Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTx-104, is a novel injectable formulation of...
379 Views
GRCE: STRIVE-ON Results Reported
Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTX-104, is a novel injectable formulation of...
357 Views